McNeil Consumer Healthcare Announces Voluntary Recall of Certain OTC Infants’ and Children’s Products
Fort Washington, PA (April 30, 2010) – McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., in consultation with the U.S. Food and Drug Administration (FDA), is voluntarily recalling all lots that have not yet expired of certain over-the-counter (OTC) Children’s and Infants’ liquid products manufactured in the United States and distributed in the United States, Canada, [...]
Rite Aid Reports 1.0 Percent Same Store Sales Decrease for April
CAMP HILL, Pa.–(BUSINESS WIRE)–Rite Aid Corporation (NYSE:RAD) today announced sales results for April.
Monthly Sales
For the four weeks ended April 24, 2010, same store sales decreased 1.0 percent over the prior-year period. April front-end same stores sales decreased 1.2 percent while pharmacy same store sales, which included an approximate 103 basis points negative impact from new [...]
Despite Concern, Americans Aren’t Protecting Themselves Against Diabetes
COLUMBUS, Ohio, April 28, 2010 - Diabetes affects more than 23 million people in the United States today and another 54 million people have pre-diabetes, according to the Centers for Disease Control and Prevention (CDC). However, while nearly 60 percent of Americans are concerned about developing diabetes, many aren’t taking the necessary steps to protect their [...]
Abbott Receives FDA Approval for Once-Daily Dosing of Kaletra (R) (lopinavir / ritonavir) for Treatment-Experienced Patients
ABBOTT PARK, Ill., April 28, 2010 - Abbott announced today that the U.S. Food and Drug Administration (FDA) approved once-daily dosing of Kaletra(R) (lopinavir/ritonavir) for adult patients with HIV who have previously taken antiretroviral therapy. Kaletra once-daily dosing is already indicated for adult patients new to antiretroviral treatment. This gives treatment-experienced patients who have HIV that [...]
Therigy Signs Extensive Services Agreement with Henry Ford Health Systems
ORLANDO, FL – Therigy, LLC announced today it has been contracted by Henry Ford Health Systems (HFHS) to provide an array of services, including designing its new facility and developing a best-in-class operation with an integrated therapy management solution to provide a higher level of care for specialty pharmacy patients.
“Therigy is excited to be chosen to [...]
Nycomed and Merck & Co., Inc., Announce Commercialization Agreements For Daxas® in Europe and Canada
ZURICH & WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Nycomed and Merck & Co., Inc. (based in Whitehouse Station, New Jersey and known as MSD outside the USA and Canada) today announced that they have entered into a co-promotion agreement for Canada and certain European countries for the commercialization of Daxas® (roflumilast), an investigational once-daily tablet for patients with [...]
Seroquel XR Recommended For Approval In EU as an Add-On Treatment Of Major Depressive Disorder
AstraZeneca today announced that the Committee for Medicinal Products for Human Use (CHMP), of the European Medicines Agency (EMA) concluded that the benefit-risk profile of once-daily SEROQUEL XR (quetiapine fumarate) extended-release tablets was positive as an add-on medication for major depressive episodes in major depressive disorder patients who have had sub-optimal response to treatment with [...]
Amylin, Lilly and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON(TM)
SAN DIEGO, INDIANAPOLIS, and WALTHAM, Mass., April 22, 2010 - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New [...]
Bristol-Myers Squibb Receives LEED® Silver Certification for its Biologics Manufacturing Facility in Devens, Massachusetts
DEVENS, Mass. – Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has received Leadership in Energy and Environmental Design (LEED®) Silver certification for its biologics manufacturing facility in Devens, Massachusetts. The laboratory and office building at the same facility received LEED Gold certification in December 2009.
LEED certification, established by U.S. Green Building Council and verified [...]
Abbott Completes Acquisition of STARLIMS Technologies
March 22, 2010 by Rick Jackson
Filed under Rx News
Abbott announced today that it has completed its $123 million acquisition of STARLIMS Technologies Ltd., a leader in laboratory information management systems.
The acquisition provides Abbott with leading products and expertise to build its position in laboratory informatics, an emerging and rapidly growing field focused on helping to manage the increasing amount of data generated in laboratories. [...]
